Active substance |
Telotristat etiprate |
Holder |
Ipsen |
Status |
Closed |
Indication |
Treatment of carcinoid syndrome diarrhea in combination with somatstatin analogue (SSA) therapy in adults inadequately controlled by SSA therapy. |
Public documents |
|
Last update |
05/11/2018 |
Xermelo
Last updated on 10/09/2024